drugset / Trial / NCT05840471

Tranexamic Acid as an Intervention in Abruptio Placenta

NCT05840471

Completed 116 enrolled Hawler Medical University
RandomizedParallel-groupDouble-blindTreatment

Summary

Abruptio placenta is one of the common causes of antepartum haemorrhage which is more common in the second half of pregnancy and causes a high maternal and neonatal morbidity and mortality

Timeline

Start
2023-01-10
Primary completion
2024-02-02
Completion
2024-02-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.